These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7213574)

  • 1. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH; Cerny EA; Rahman YE
    Br J Haematol; 1981 Apr; 47(4):505-18. PubMed ID: 7213574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH; Cerny EA; Wright BJ; Rahman YE
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE; Cerny EA; Lau EH; Carnes BA
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C
    Blood; 1978 Mar; 51(3):415-23. PubMed ID: 623907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G; Link G; Simhon E; Cyjon RL; Klein JY; Hershko C
    Blood; 1997 Nov; 90(10):4180-7. PubMed ID: 9354689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy.
    Young SP; Baker E; Huehns ER
    Br J Haematol; 1979 Mar; 41(3):357-63. PubMed ID: 427040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE; Torrance JD; Bothwell TH; Simon MO; Charlton RW
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the iron chelator desperrioxamine as affected by liposome encapsulation: potential in treatment of chronic hemosiderosis.
    Guilmette RA; Cerny EA; Rahman YE
    Life Sci; 1978 Jan; 22(4):313-20. PubMed ID: 622008
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary iron excretion in rats following pyridoxal isonicotinoyl hydrazone.
    Cikrt M; Ponka P; Necas E; Neuwirt J
    Br J Haematol; 1980 Jun; 45(2):275-83. PubMed ID: 7437326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin iron kinetics and protein turnover in K562 cells.
    Roberts S; Bomford A
    J Biol Chem; 1988 Dec; 263(35):19181-7. PubMed ID: 3198619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental study on the pathway of iron transfer from macrophages to erythrocytes in rat liver.
    Ono T; Akita M; Tsujii T; Seno S
    Cell Struct Funct; 1989 Feb; 14(1):61-74. PubMed ID: 2720798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved animal model for studying desferrioxamine.
    Steward A; Williamson I; Madigan T; Bretnall A; Hassan IF
    Br J Haematol; 1996 Dec; 95(4):654-9. PubMed ID: 8982041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the mechanisms and sites of action of desferrioxamine in thalassaemia major.
    Bianco I; Graziani B; Lerone M; Congedo P; Clemente GF; Ingrao G; Ciccone F; Di Nucci GD; Mandelli F; Isacchi G
    Acta Haematol; 1984; 71(2):100-5. PubMed ID: 6421046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid assay for evaluation of iron-chelating agents in rats.
    Pippard MJ; Johnson DK; Finch CA
    Blood; 1981 Oct; 58(4):685-92. PubMed ID: 7272500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R; Thévenin M; Bouveret JP; Jeannel F; Rymer JC
    Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of intravenously injected tissue ferritin in pregnant guinea-pigs.
    Lamparelli RD; Friedman BM; MacPhail AP; Bothwell TH; Phillips JI; Baynes RD
    Br J Haematol; 1989 May; 72(1):100-5. PubMed ID: 2736234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.